QMS Medical Allied Services revenue hits ₹30.37 crore in Q1FY25

New Delhi: For the first quarter ending June 30, 2024, QMS Medical Allied Services achieved an operating income of ₹30.37 crore. This figure represents a minor decline of 6% from ₹32.29 crore in Q4FY24 but marks a significant year-on-year increase of 17% from ₹25.96 crore in Q1FY24. 

EBITDA saw a notable improvement of 22% quarter-on-quarter, rising to ₹4.95 crore from ₹4.06 crore in Q4FY24. Year-over-year, EBITDA grew by 4% compared to ₹4.74 crore in Q1FY24.

The company’s net profit surged by 56% to ₹2.40 crore in Q1FY25, compared to ₹1.54 crore in the previous quarter. This increase highlights a shift in the company’s business model from product-based offerings to a solutions-oriented approach, contributing to improved margins.

The earnings per share (EPS) also saw a substantial rise, reaching ₹1.34, up from ₹0.86 in Q4FY24. On a year-over-year basis, PAT decreased slightly by 3% from ₹2.46 crore in Q1FY24, but the overall performance reflects the company’s strategic transition and growth. EPS for Q1FY24 was ₹1.38.

Mahesh Makhija, Founder, Chairman, and Managing Director of QMS Medical Allied Services, commented on the results: “The quarter was headlined by India’s national elections, which led to lower activation and on-ground programs. However, the operating margins improved owing to the company’s ongoing shift from products to solutions ecosystem play. The quarter also witnessed the acquisition of a 51% stake in Saarathi Healthcare – which has added a new dimension to the company’s opportunity landscape.”